Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About

Trending Topics

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni

    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor & Employment
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations

    Industries

    View All

    • Cannabis
    • Consumer
    • Energy
    • Entertainment
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Non Profit
    • Real Estate
    • Technology

    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    1. Home
    2. Insights
    3. Alerts
    4. The FTC and DOJ offer seven-day review of proposed collaborative arrangements to respond to COVID-19Alerts

    Alert / Antitrust Law Alert

    The FTC and DOJ offer seven-day review of proposed collaborative arrangements to respond to COVID-19

    March 30, 2020

    Share

    By Brian Whittaker and Gordon Lang

    The FTC and DOJ issued a joint statement announcing an expedited antitrust procedure to provide guidance to individuals and businesses seeking to collaborate to respond to the COVID-19 pandemic.

    On March 24, 2020, the U.S. Federal Trade Commission (FTC) and Department of Justice (DOJ) issued a joint statement announcing an expedited antitrust procedure to provide guidance to individuals and businesses seeking to collaborate to protect the health and safety of Americans during the COVID-19 pandemic. [1]

    The FTC and the DOJ already had a process for individuals and businesses seeking an evaluation of proposed conduct, but the agencies typically take several months to complete an evaluation. Now, the FTC and DOJ will attempt to respond within seven (7) calendar days of receiving all necessary information about proposed collaborative arrangements to address public health and safety issues related to the COVID-19 pandemic.

    The joint statement also includes examples of collaborative arrangements to respond to COVID-19 that will generally be consistent with antitrust laws, including:

    • collaboration on research and development;
    • sharing technical information and knowledge, rather than company-specific prices, wages, outputs, or costs;
    • development and sharing of best practices and standards for health care providers that might be useful for patients, providers, and purchasers;
    • most joint purchasing arrangements among health care providers, particularly those intended to enhance procurement efficiencies and reduce costs;
    • private lobbying related to use of federal emergency authority, including private industry meetings with the federal government regarding strategies to respond to COVID-19;
    • joint efforts by health care facilities that are limited in duration and necessary to assist patients, consumers, and communities affected by COVID-19; and
    • assistance of the federal government by private businesses to respond to COVID-19, such as working with agencies to implement the Defense Production Act and the Pandemic and All-Hazards Preparedness Act.

    Nevertheless, the FTC and DOJ warn in the joint statement that they “will not hesitate to hold accountable” individuals and businesses that engage in anticompetitive conduct, including “agreements between individuals and business[es] to restrain competition through increased prices, lower wages, decreased output, or reduced quality as well as efforts by monopolists to use their market power to engage in exclusionary conduct.” In particular, DOJ will investigate and criminally prosecute price-fixing, bid-rigging, or market allocation schemes.

    As a result, businesses should not prematurely enter into collaborative arrangements with competitors to respond to the COVID-19 pandemic. Instead, they should consult with antitrust counsel to evaluate whether proposed arrangements are consistent with antitrust laws and to consider whether a submission to the FTC and DOJ using the expedited antitrust procedure would be appropriate.


    1. U.S. Federal Trade Commission & U.S. Department of Justice, “Joint Antitrust Statement Regarding COVID-19” (Mar. 24, 2020), available at https://www.ftc.gov/system/files/documents/public_statements/1569593/statement_on_coronavirus_ftc-doj-3-24-20.pdf and https://www.justice.gov/atr/joint-antitrust-statement-regarding-covid-19. [Back to reference]

    Practices

    M&A and Corporate TransactionsPrivate Equity & Investment FundsSecurities & Capital MarketsGovernment Investigations & White Collar DefenseCongressional InvestigationsHealthcareAntitrustExport Controls & Economic Sanctions

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      Focus on COVID-19 fraud and price gouging results in federal criminal charges under the Defense Production Act of 1950

      April 30, 2020
    • Alert

      DOJ completes its first expedited antitrust review of collaborative efforts by businesses to respond to COVID-19

      April 9, 2020
    • Alert

      SBA issues interim final rule clarifying changes to PPP loans for eligible businesses

      April 3, 2020

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • © 2023 Nixon Peabody. All rights reserved
    • Privacy Policy
    • Terms of Use
    • Statement of Client Rights
    • Supplier Diversity Program
    • Nixon Peabody International LLC
    • PAL